Reduce stroke risk for AFib patients with left atrial appendage closure (LAAC)

Patients with nonvalvular atrial fibrillation (AFib) are five to seven times more likely to have a stroke. For these patients, a part of the heart called the left atrial appendage (LAA) may be the “most lethal human attachment;” more than 90% of stroke-causing clots are formed in the LAA.

Traditionally, doctors prescribe blood thinner medication to reduce stroke risk. But many patients don’t like taking blood thinners or cannot due to other medical reasons.

Denver Heart offers two minimally invasive procedures that are successfully treating AFib patients without blood thinners.

LAA closure device: Shaped like a parachute and about the size of a quarter, the device is placed with minimally invasive techniques. The tissue grows around the device and the LAA is sealed permanently.

LAA suture loop: A lasso-shaped suture is looped around the base of the LAA, permanently sealing it off from the heart.

Benefits of our LAAC procedures

  • Performed with minimally invasive tools and techniques
  • High success rate
  • Relieves symptoms
  • Improves quality of life
  • Permanent, one-time solution

To learn more about LAAC and reducing your stroke risk while living with AFib, contact us at (303) 331-9121.